This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Paul J A Hartman Kok: Innovator in Prostate Cancer Treatment
Introduction
Paul J A Hartman Kok is a notable inventor based in Eersel, Netherlands. He has made significant contributions to the field of cancer treatment, particularly focusing on prostate cancer. His innovative approach combines various pharmaceutical compounds to enhance treatment efficacy.
Latest Patents
Paul J A Hartman Kok holds a patent for the treatment of prostate cancer using a combination of abiraterone acetate, niraparib tosylate monohydrate, and prednisone. The patent details methods of treatment that involve both free-dose and fixed-dose combinations of these compounds. This innovative combination aims to improve patient outcomes in prostate cancer therapy.
Career Highlights
He is currently associated with Janssen Pharmaceutica NV, a leading pharmaceutical company known for its commitment to developing advanced medical solutions. His work at Janssen has allowed him to focus on groundbreaking research and development in oncology.
Collaborations
Some of his notable coworkers include Thomas Ronald A Quinten and Urbain Alfons C Delaet. Their collaborative efforts contribute to the advancement of cancer treatment methodologies.
Conclusion
Paul J A Hartman Kok's contributions to prostate cancer treatment through his innovative patent reflect his dedication to improving patient care. His work continues to influence the field of oncology and offers hope for better treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile